Position
Fidelity in Arcutis Biotherapeutics, Inc.
Back to the book · All holders of ARQT
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $741.4K$23.56 → $26.22
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 205.4K | $5.97M | — | — | — | 0.0% |
| Q1 2026 | 278.7K | $6.57M | $23.56 | −$1.13M | $1.73M | 0.0% |
| Q2 2026 | 306K | $8.02M | $26.22 | $741.4K | $714K | 0.0% |